Cited by 31Liver physiology and pathologyOrgan Transplantation Techniques and OutcomesDrug-Induced Hepatotoxicity and Protection

Regulation of liver regeneration by interleukin-2 and its inhibitors: Cyclosporine A and FK 506

Tanaka, Noriaki, Yamamoto, Hiroshi, Tatemoto, Akihiko, Urabe, Takamitsu, Orita, Kunzo·1993·International Journal of Immunopharmacology

Abstract

Several investigations have been suggesting that lymphocytes can be responsible for growth regulation of liver. The interleukin-2 (IL-2) production by spleen cells was noted to be increased 2 days after resection of 70% of the volume of the liver in C3H/He mice. The effects of IL-2 production and its antagonists: cyclosporine A (CsA) and FK506 on liver regeneration were thus studied by measuring in vivo incorporation of Bromodeoxyuridine (BrdU). By intraperitoneal injection of IL-2 5 times every 8 h after hepatectomy. BrdU labeling indices at 36 h after the operation were suppressed in a dose-dependent manner. On the other hand, treatment with CsA and FK506, which inhibit IL-2 production, increased the mitotic indices of the regenerating livers. Serum levels of aminotransferases were not affected by FK506 at a dose sufficient for the mitotic stimulation. Based on these results, CsA and FK506 would appear to stimulate liver cell proliferation by suppressing IL-2 production and inhibiting of NK cell activity.

Integrity signals

Registry

Crossref · 10.1016/0192-0561(93)90097-i

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Elevated concentrations of IL-2 and IL-18 contribute to inhibiting liver growth and downregulating regenerative processes.

    “Additionally, elevated concentrations of IL-2 and IL-18 contribute to inhibiting liver growth and downregulating regenerative processes[98,99].”

Cited by

Sorted by citations

Authors
Tanaka, N., Yamamoto, H., Tatemoto, A., Urabe, T., & Orita, K.
Affiliations
Okayama University (JP)
Corresponding author
Tanaka, Noriaki
Venue
International Journal of Immunopharmacology
Publisher
Elsevier BV
Published
1993-02
Volume
15
Issue
2
Pages
211-218
ISSN
0192-0561 (ISSN-L)
OpenAlex
W2067435893
Cited by
31
References
0
Citations by year
2025: 2 · 2023: 1 · 2022: 1 · 2017: 1 · 2016: 2 · 2014: 1 · 2012: 1
FWCI
1.96
Type
journal article
Language
en
Open access
closed
Locations
  • International Journal of Immunopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords
liver regeneration, interleukin-2, cyclosporine, FK506, hepatectomy, liver cell proliferation, mitotic index, NK cell cytotoxicity, transaminases, C3H/He mice
MeSH terms
Animals, Hepatectomy, Interleukin-2, Killer Cells, Natural, Liver Regeneration, Male, Mice, Inbred C3H, Spleen, Killer Cells, Lymphokine-Activated, Tacrolimus, Cyclosporine, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review